A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders

A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders

Alzheimer's disease (AD) is the most prevalent neurodegenerative condition, especially among elderly people. The presence of cortical β-amyloid deposition, together with tau phosphorylation and intracellular accumulation of neurofibrillary tangles (NFT) is the main neuropathologic criteria for...

Full description

Bibliographic Details
Main Authors:	Sagrario Manzano, Luis Agüera, Miquel Aguilar, Javier Olazarán
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-07-01
Series:	Frontiers in Neurology
Subjects:	homotaurine tramiprosate amyloid Alzheimer's disease neurocognitive disorders neurodegenerative diseases
Online Access:	https://www.frontiersin.org/article/10.3389/fneur.2020.00614/full

Similar Items

Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
by: Paola Bossù, et al.
Published: (2018-11-01)

Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer’s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression
by: Martin Tolar, et al.
Published: (2021-06-01)

Extraction and measurement of homotaurine in algae
Published: (2017-11-01)

HOMOTAURINE INDUCES MEASURABLE CHANGES OF SHORT LATENCY AFFERENT INHIBITION IN A GROUP OF MILD COGNITIVE IMPAIRMENT INDIVIDUALS
by: Alessandro eMartorana, et al.
Published: (2014-09-01)

Association of Ultrapure Citicoline, Homotaurine and Vitamin E in the Management of Normotensive Glaucoma: A Case Report
by: Tommaso Verdina, et al.
Published: (2020-06-01)

Anti-inflammatory Effect of Curcumin, Homotaurine, and Vitamin D3 on Human Vitreous in Patients With Diabetic Retinopathy
by: Mariaelena Filippelli, et al.
Published: (2021-02-01)

Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
by: Soghra Bagheri, et al.
Published: (2018-01-01)

Effects of Citicoline, Homotaurine, and Vitamin E on Contrast Sensitivity and Visual-Related Quality of Life in Patients with Primary Open-Angle Glaucoma: A Preliminary Study
by: Pier Franco Marino, et al.
Published: (2020-11-01)

Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease
by: Aydin EY, et al.
Published: (2020-02-01)

Current approaches to diagnosing and treating major neurocognitive disorder
by: A. A. Kulesh, et al.
Published: (2017-12-01)

Aggregation Inhibition and Detection of Alzheimer’s Amyloidogenic and Oligomeric Peptides

Vascular neurocognitive disorders and the vascular risk factors
by: Carmen V. Albu, et al.
Published: (2018-04-01)

Sporadic Creutzfeldt-Jakob Disease and Other Proteinopathies in Comorbidity
by: Eva Parobkova, et al.
Published: (2020-11-01)

Link Between Diabetes and Alzheimer’s Disease due to the Shared Amyloid Aggregation and Deposition Involving both Neurodegenerative Changes and Neurovascular Damages
by: Gabriela Dumitrita Stanciu, et al.
Published: (2020-06-01)

Site-specific structural order in Alzheimer's Aβ42 fibrils
by: Hongsu Wang, et al.
Published: (2018-01-01)

The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer’s Disease and Parkinson’s Disease
by: Patrycja Pawlik, et al.
Published: (2021-02-01)

Periodontitis and Alzheimer’s Disease: A Possible Comorbidity between Oral Chronic Inflammatory Condition and Neuroinflammation
by: Francisco B. Teixeira, et al.
Published: (2017-10-01)

Pathophysiology of Alzheimer’s Disease
by: Mohammad Amani
Published: (2017-01-01)

Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
by: Masaru Tanaka, et al.
Published: (2020-03-01)

The potential applications of Apolipoprotein E in personalized medicine
by: Sylvia eVilleneuve, et al.
Published: (2014-07-01)

EFhd2, a protein linked to Alzheimer’s disease and other neurological disorders
by: Irving E Vega
Published: (2016-03-01)

Computerized Neurocognitive Test (CNT) in mild cognitive impairment and Alzheimer's disease
by: Maira Okada de Oliveira, et al.

Royal Jelly as an Intelligent Anti-Aging Agent—A Focus on Cognitive Aging and Alzheimer’s Disease: A Review
by: Amira Mohammed Ali, et al.
Published: (2020-09-01)

A Possible Association Between Executive Dysfunction and Frailty in Patients With Neurocognitive Disorders
by: Massimo Bartoli, et al.
Published: (2020-11-01)

Seeding and Growth of β-Amyloid Aggregates Upon Interaction with Neuronal Cell Membranes
by: Álvaro Ruiz-Arias, et al.
Published: (2020-07-01)

Molecular insights into the primary nucleation of polymorphic amyloid β dimers in DOPC lipid bilayer membrane
by: Miller, Y., et al.
Published: (2022)

Mast Cells in Stress, Pain, Blood-Brain Barrier, Neuroinflammation and Alzheimer’s Disease
by: Duraisamy Kempuraj, et al.
Published: (2019-02-01)

Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease
by: Soumitra Ghosh, et al.
Published: (2015-11-01)

Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease
by: Toshitaka Ochiai, et al.
Published: (2021-11-01)

Current Cognition Tests, Potential Virtual Reality Applications, and Serious Games in Cognitive Assessment and Non-Pharmacological Therapy for Neurocognitive Disorders
by: Roger Jin, et al.
Published: (2020-10-01)

Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes
by: Ana Espinosa, et al.
Published: (2018-10-01)

Is Alzheimer's Disease Infectious?<br><i>Relative to the CJD Bacterial Infection Model of Neurodegeneration</i>
by: Frank O. Bastian
Published: (2015-11-01)

Facts and speculations on the infectious nature of Alzheimer’s disease
by: Katarzyna Bilińska, et al.
Published: (2018-09-01)

Use of a Neurotrophic Factor Mimetic to Block Amyloid Toxicity in Alzheimer's Disease Models
by: Rawal, Devika
Published: (2010)

Sleep Time Estimated by an Actigraphy Watch Correlates With CSF Tau in Cognitively Unimpaired Elders: The Modulatory Role of APOE
by: Sara López-García, et al.
Published: (2021-08-01)

A continuous-time mathematical model and discrete approximations for the aggregation of β-Amyloid
by: Azmy S. Ackleh, et al.
Published: (2021-01-01)

Relevance of biomarkers across different neurodegenerative
by: Alexander J. Ehrenberg, et al.
Published: (2020-05-01)

Behavioural and psychological symptoms in neurocognitive disorders: Specific patterns in dementia subtypes
by: Majer Réka, et al.
Published: (2019-04-01)

Neuropsychiatric Symptoms in Patients with the Main Etiological Types of Mild Neurocognitive Disorders: A Hospital-Based Case–Control Study
by: Oleg A. Levada, et al.
Published: (2017-05-01)

How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer’s Disease and Other Neurodegenerative Disorders
by: George A. Carlson, et al.
Published: (2021-05-01)